Head and Neck Imaging
Clinical Application of Flurbiprofen Axetil and Sufentanil in the Patient-controlled Intravenous Analgesia for Burnt Patients
Author:LUO Qing, HUANG Min-zhen, DU Wen-wen
affiliation:Department of Anesthesiology, Sanshui People’s Hospital of Foshan City, Foshan 528100, Guangdong Province, China
PDFAbstract
Objective To relieve the patient’s pain degree and explore the feasibility of Flurbiprofen Axetil and Sufentanil in the burnt patient’s analgesia. Methods 80 burnt patients treated from January 2015 to March 2016 in our hospital were selected. Based on the double-blind method, the subjects were randomly divided into two groups, 40 cases each group. The single group just took Sufentanil, the combined group took the combined therapy of Flurbiprofen Axetil and Sufentanil. The pain degree and adverse reactions were observed. Results The adverse event rate for single group (22.5%) was higher than combined group (10.0%) (P<0.05), before treatment, the pain degree for two groups was not significantly different (P>0.05), after treatment, the pain degree for combined group was milder than single group (P<0.05). Conclusion During the patient-controlled intravenous analgesia, the combined therapy of Flurbiprofen Axetil and Sufentanil can reduce the patient’s pain degree and adverse event rate in clinical practice.
【Keyword】Analgesia; Adverse Reaction; Sufentanil; Burnt; Flurbiprofen Axetil
【Chart number】R971
【Document Identification Number】A
【DOI】10.3969/j.issn.1009-3257.2018.03.031
Journal of Rare Diseases
th25Volume, th 3 Issue
2019Year11Month
Related articles